USPH
HealthcareU.S. Physical Therapy, Inc. · Medical - Care Facilities · $940M
What is U.S. Physical Therapy, Inc.?
U.S. Physical Therapy operates a nationwide network of outpatient physical therapy clinics, serving patients recovering from orthopedic conditions, sports injuries, and workplace incidents across the United States.
The company runs two segments: Physical Therapy Operations and Industrial Injury Prevention Services. Clinic revenue comes from patient care, while the industrial segment provides onsite injury prevention, ergonomic assessments, and rehabilitation programs to large employers, insurers, and their contractors.
Founded in 1990 and headquartered in Houston, Texas, the company has grown to operate clinics across dozens of states.
- Outpatient physical therapy clinics
- Pre- and post-operative orthopedic rehabilitation
- Industrial injury prevention and onsite rehabilitation
- Functional capacity evaluations and ergonomic assessments
Is USPH a Good Stock to Buy?
UQS Score rates USPH as Below Average overall.
Valuation is the standout pillar, rating Good — meaning the stock may not carry the premium pricing seen in stronger healthcare peers. Growth sits at a Neutral rating, suggesting the business is moving forward without notable acceleration.
Quality, Moat, and Risk all rate Weak, pointing to structural challenges in profitability, competitive positioning, and balance sheet resilience.
See the exact pillar breakdown and full financial metrics by signing up for a Pro account at UQS Score. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does USPH pay dividends?
Yes — U.S. Physical Therapy, Inc. pays a dividend.
USPH pays a regular dividend, which may appeal to income-oriented investors in the healthcare services space. Given the company's Weak Quality and Risk ratings, investors should weigh dividend sustainability carefully against the underlying financial profile.
When does USPH report earnings?
U.S. Physical Therapy reports earnings on a quarterly cadence, typical for US-listed equities.
The company's Neutral Growth rating suggests results have been steady rather than standout. Clinic count expansion and industrial services contracts are the primary levers management can pull to drive top-line progress.
For the most recent quarter's results, visit U.S. Physical Therapy's investor relations page directly.
USPH Price History
-29.0% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
Frequently Asked Questions
What does U.S. Physical Therapy do?
U.S. Physical Therapy operates outpatient clinics treating orthopedic injuries, sports injuries, and neurological conditions. It also provides industrial injury prevention services — including onsite rehabilitation and ergonomic assessments — to large employers and insurers through its second business segment.
Does USPH pay dividends?
Yes, USPH pays a regular dividend. Income investors should review the company's investor relations page for current dividend details, and consider the Weak Risk and Quality ratings when assessing long-term dividend reliability.
When does USPH report earnings?
U.S. Physical Therapy reports on a standard quarterly schedule. Our data source does not publish specific upcoming earnings dates — check the company's investor relations page or a financial calendar for the next scheduled release.
Is USPH a good stock to buy?
UQS Score rates USPH as Below Average, reflecting Weak scores across Quality, Moat, and Risk. The Valuation pillar rates Good, which may interest value-oriented investors, but the broader profile warrants careful review before committing capital.
Is USPH overvalued?
The Valuation pillar for USPH rates Good, suggesting the stock is not trading at a significant premium relative to its fundamentals. However, a favorable valuation label alone does not offset the Weak ratings in other pillars.
What is USPH's market cap bracket?
USPH is classified as a small-cap stock. Small-cap healthcare services companies can offer growth potential but often carry higher volatility and liquidity risk compared to large- or mega-cap peers.
Is USPH a long-term quality investment?
As a long-term quality indicator, USPH's Below Average UQS Score — driven by Weak Quality, Moat, and Risk ratings — suggests the business currently lacks the durable characteristics typically associated with long-term compounders. Pro members can view the complete pillar analysis.
What sector does USPH belong to?
USPH operates in the Healthcare sector, specifically within outpatient physical therapy and industrial health services. The sector can offer defensive characteristics, but individual company quality varies widely — as reflected in USPH's pillar-level ratings.
Unlock Full USPH Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS pillar scores across Quality, Moat, Growth, Risk, and Valuation
- ✓Access full financial metrics and trend data
- ✓Compare USPH side-by-side with sector peers
- ✓Get the complete analyst-style breakdown available to Pro members
Pro Analysis
USPH — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | 40.5 | 30.7 | 27.0 | 49.7 | 33.3 | 74.2 | -0.1 |
| May 14, 2026 | 40.6 | 31.2 | 27.0 | 49.3 | 33.3 | 74.7 | 0.0 |
| May 12, 2026 | 40.6 | 31.4 | 27.0 | 49.3 | 33.3 | 74.1 | -0.7 |
| May 9, 2026 | 41.3 | 34.1 | 27.0 | 49.3 | 33.2 | 74.4 | +1.6 |
| May 7, 2026 | 39.7 | 32.0 | 27.0 | 49.2 | 31.2 | 69.5 | -0.1 |
| May 3, 2026 | 39.8 | 32.0 | 27.0 | 49.2 | 31.2 | 70.1 | +0.1 |
| Apr 29, 2026 | 39.7 | 32.0 | 27.0 | 49.2 | 31.2 | 69.5 | +0.2 |
| Apr 26, 2026 | 39.5 | 32.0 | 27.0 | 48.4 | 31.2 | 69.4 | -0.1 |
| Apr 19, 2026 | 39.6 | 32.0 | 27.0 | 48.4 | 31.2 | 69.7 | +0.3 |
| Apr 18, 2026 | 39.3 | 32.0 | 27.0 | 48.4 | 31.2 | 68.0 | -0.6 |
USPH — Pillar Breakdown
Quality
— 30.8/100 (25%)U.S. Physical Therapy, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 49.7/100 (20%)U.S. Physical Therapy, Inc. shows steady but unspectacular growth, typical for mature companies.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 33.3/100 (15%)U.S. Physical Therapy, Inc. presents elevated risk with concerns around leverage or financial stability.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 74.5/100 (15%)U.S. Physical Therapy, Inc. trades at a reasonable valuation with decent earnings yield and FCF multiples.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 27/100 (25%)U.S. Physical Therapy, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for USPH.
Score Composition
Financial Data
More Stock Analysis
How is the USPH UQS Score Calculated?
The UQS (Unified Quality Score) for U.S. Physical Therapy, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses U.S. Physical Therapy, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether U.S. Physical Therapy, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.